Keywords: taxotere, outperforms, standard, drugs, breast, cancer, rhone-poulenc

Taxotere Outperforms Standard Drugs In Breast Cancer

Article | 30 May 1997

Rhone-Poulenc Rorer's Taxotere (docetaxel) has become the first drug tooutperform doxorubicin in the treatment of patients with metastatic breast cancer, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Taxotere

docetaxel

Carac

Mitomycin

Efudex

Go to drug listing